Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00538915
Brief Title: Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

First Submitted : October 1, 2007
First Submitted that Met QC Criteria : October 1, 2007
First Posted : October 3, 2007 (Estimate)

Results First Submitted : January 4, 2012
Results First Submitted that Met QC Criteria : February 23, 2012
Results First Posted : March 26, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : January 30, 2017
Last Update Posted : March 10, 2017